Lopez-Talavera, Juan Carlos <br/><br/>
Hepatocyte growth factor gene therapy for pancreatic islets in diabetes: reducing the minimal islet transplant mass required in a glucocorticoid-free rat model of allogeneic portal vein islet transplantation.  [electronic resource] 

 -  Endocrinology  Feb 2004 
 - 467-74 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0013-7227 
<br/><br/><label>Standard No.: </label>10.1210/en.2003-1070  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenoviridae--genetics<br/>Animals<br/>Gene Expression<br/>Genetic Therapy<br/>Genetic Vectors<br/>Glucocorticoids--administration & dosage<br/>Graft Survival<br/>Hepatocyte Growth Factor--genetics<br/>Immunosuppressive Agents--administration & dosage<br/>Insulin--blood<br/>Insulin Resistance<br/>Islets of Langerhans--drug effects<br/>Islets of Langerhans Transplantation--methods<br/>Male<br/>Mice<br/>Portal Vein<br/>Rats<br/>Rats, Inbred Lew<br/>Rats, Sprague-Dawley<br/>Reverse Transcriptase Polymerase Chain Reaction<br/>Transfection<br/>Transplantation, Homologous